XinGang Medicine is a pharmaceutical company specializing in drug developing, manufacturing and marketing in China. Our company was established and invested by Nanjing XinGang Hi-tech Ltd. (listed on Shanghai Stock Exchange, 600644) in 2003.
XinGang Medicine has successfully built a manufacturing base and a marketing infrastructure. A strong and efficient R&D department has developed more than 20 prospecting products. Currently, it is focused in the areas of cardiovasology, neurology, urinology and gynaecology.
Our company has a total staff of 305 in five wholly owned or share-holding enterprises, including three GMP certified pharmaceutical factories, one drug commercial company and one chain drug store. Half of the employees own Bachelor degrees or above. The senior management team has a strong pharmaceutical background with profound understanding of Chinese market environment. These form the core competition elements that effectively combine with other five disciplines (manufacturing, pre-clinical, clinical trail, regulatory and marketing). This integration is the main force in driving forward our business operation.
We promote continuous research and development of medicine that meet the challenges of increasingly sophisticated market environments. Our technical expertise ensures that we provide data supported answers to technical questions. Our goal is to provide top quality products to fit the needs of each customer.
Our company's rapid market growth is a result of our strategic nationwide sales network structure. A series of selected products manufactured by XinGang Medicine and by other companies rounds off our product range. We continue to seek new opportunities to cooperate with additional prestigious groups worldwide, for manufacturing and distributing purposes.